Semaglutide is a GLP-1 receptor agonist, targeting one specific pathway
GLP-1 medications can support weight loss and blood sugar management, but their benefits are best realized when combined with healthy lifestyle choices
Renal expression of rGLP-1 has not been fully characterized due to insufficient specificity and sensitivity of the antibodies used, although it have been non-uniformly detected in endothelial cells, macrophages, juxtaglomerular cells and proximal tubule in several animal models and human tissue
This study reveals that Satb2 deficiency leads to reduced production of PYY, an enteroendocrine hormone
Lilly's December 2025 TRIUMPH-4 topline report said the highest studied arm averaged 28.7% body weight loss at 68 weeks in adults with obesity and knee osteoarthritis
it is a set of conditions with different drivers, so one breakthrough rarely helps everyone, Shamsa Kanwal, a board-certified dermatologist with over 10 years of clinical experience, told DDN
